Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis

Objectives: This systematic review and meta-analysis aimed at summarizing the evidence of efficacy and safety of rituximab in rheumatoid arthritis-related interstitial lung disease (RA-ILD). Materials and methods: PubMed and Embase databases were searched until June 22, 2022, to identify studies...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Turkish Society of Gastroenterology 2024-06-01
Edice:	The Turkish Journal of Gastroenterology
Témata:	Anti-CD20 meta-analysis rheumatoid arthritis-related interstitial lung disease rituximab.
On-line přístup:	http://avestema.com.dedi9374.your-server.de/index.php/pub/article/view/1421
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!